These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31304451)
1. OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma. Ashizawa Y; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M Hepatol Commun; 2019 Jul; 3(7):954-970. PubMed ID: 31304451 [TBL] [Abstract][Full Text] [Related]
2. LGR5 induces β-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma. Kawasaki K; Kuboki S; Furukawa K; Takayashiki T; Takano S; Ohtsuka M Liver Int; 2021 Apr; 41(4):865-881. PubMed ID: 33249719 [TBL] [Abstract][Full Text] [Related]
3. TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma. Sakamoto T; Kuboki S; Furukawa K; Takayashiki T; Takano S; Yoshizumi A; Ohtsuka M Liver Int; 2023 Jan; 43(1):194-207. PubMed ID: 35753056 [TBL] [Abstract][Full Text] [Related]
4. Expressions and clinical significances of STAT3 and Grim19 in epithelial ovarian cancer. Wang Y; Yan Y; Yang M; Yang Z 3 Biotech; 2020 Jun; 10(6):246. PubMed ID: 32411570 [TBL] [Abstract][Full Text] [Related]
5. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936 [TBL] [Abstract][Full Text] [Related]
6. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients. Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924 [TBL] [Abstract][Full Text] [Related]
7. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation. Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
9. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression. Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 predicts poor prognosis in hepatocellular carcinoma. Chen W; Fu Q; Fang F; Fang J; Zhang Q; Hong Y Saudi J Biol Sci; 2018 Jul; 25(5):904-908. PubMed ID: 30108439 [TBL] [Abstract][Full Text] [Related]
11. Identification of cells expressing OLFM4 and LGR5 mRNA by in situ hybridization in the yolk sac and small intestine of embryonic and early post-hatch chicks. Zhang H; Wong EA Poult Sci; 2018 Feb; 97(2):628-633. PubMed ID: 29155957 [TBL] [Abstract][Full Text] [Related]
12. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells. Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346 [TBL] [Abstract][Full Text] [Related]
13. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth. Okamoto T; Inozume T; Mitsui H; Kanzaki M; Harada K; Shibagaki N; Shimada S Mol Cancer Ther; 2010 Aug; 9(8):2333-43. PubMed ID: 20682646 [TBL] [Abstract][Full Text] [Related]
16. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote the stemness of CD24 Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864 [TBL] [Abstract][Full Text] [Related]
18. Grim19 Attenuates DSS Induced Colitis in an Animal Model. Kim JK; Lee SH; Lee SY; Kim EK; Kwon JE; Seo HB; Lee HH; Lee BI; Park SH; Cho ML PLoS One; 2016; 11(6):e0155853. PubMed ID: 27258062 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway. Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Mano Y; Aishima S; Fujita N; Tanaka Y; Kubo Y; Motomura T; Taketomi A; Shirabe K; Maehara Y; Oda Y Pathobiology; 2013; 80(3):146-54. PubMed ID: 23364389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]